These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 4200376)

  • 21. [Development and present status of immunoprophylaxis of Rh-sensitization].
    Radzuweit H
    Z Arztl Fortbild (Jena); 1970 Dec; 64(3):1181-5. PubMed ID: 4994101
    [No Abstract]   [Full Text] [Related]  

  • 22. [Hemolytic disease of the newborn from the viewpoint of the pediatrician].
    Janovský M; Polácek K
    Cesk Gynekol; 1969 Oct; 34(8):485-8. PubMed ID: 4982153
    [No Abstract]   [Full Text] [Related]  

  • 23. Levels of wo components of complement (C'4 and C'3) in human fetal and newborn sera.
    Adinolfi M
    Dev Med Child Neurol; 1970 Jun; 12(3):306-8. PubMed ID: 5433147
    [No Abstract]   [Full Text] [Related]  

  • 24. [Unusual aspects of neonatal hemolytic disease].
    Lange MM; Lumare A; Baratono S
    Minerva Pediatr; 1967 Aug; 19(31):1466-7. PubMed ID: 4975678
    [No Abstract]   [Full Text] [Related]  

  • 25. [Prenatal prognosis of the hemolytic disease of the newborn].
    Polácek K; Zwinger A; Vedra B
    Cesk Gynekol; 1972 Jun; 37(6):423-7. PubMed ID: 4626308
    [No Abstract]   [Full Text] [Related]  

  • 26. Complement in ABO--hemolytic disease of the newborn.
    Wang MY; Desforges JF
    Pediatrics; 1971 Oct; 48(4):650-3. PubMed ID: 5165506
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of Rh hemolytic disease by passive immunization.
    Hart GD
    Appl Ther; 1967 Apr; 9(4):372-4. PubMed ID: 4962682
    [No Abstract]   [Full Text] [Related]  

  • 28. [Hemolytic disease of newborn caused by anti-c antibody].
    Tóth A; Vágvölgyi E; Trézli I
    Orv Hetil; 1982 Aug; 123(32):1983-4. PubMed ID: 6815609
    [No Abstract]   [Full Text] [Related]  

  • 29. [Prevention of hemolytic disease of the newborn with anti-D administration to the mother. 2].
    Dtsch Med Wochenschr; 1968 Jun; 93(24):1176-9. PubMed ID: 4967928
    [No Abstract]   [Full Text] [Related]  

  • 30. [3 cases of anti-c(hr') isoimmunization-induced hemolytic disease of the newborn].
    Lange MM; Lumare A
    Minerva Pediatr; 1972 Feb; 24(4):148-52. PubMed ID: 4622335
    [No Abstract]   [Full Text] [Related]  

  • 31. [Indication, timing and methods of labor induction before term in fetal hemolytic disease].
    Mast H
    Med Klin; 1967 Nov; 62(47):1842-6. PubMed ID: 4968501
    [No Abstract]   [Full Text] [Related]  

  • 32. [Hemolytic disease of the newborn due to anti-E. Case report].
    Schneider W; Dahl J vom
    Geburtshilfe Frauenheilkd; 1967 Sep; 27(9):900-3. PubMed ID: 4969211
    [No Abstract]   [Full Text] [Related]  

  • 33. [Immunosuppressive agents in Rh immunization].
    Onnis A
    Attual Ostet Ginecol; 1969; 15(2):89-95. PubMed ID: 4998491
    [No Abstract]   [Full Text] [Related]  

  • 34. [Hemolytic disease of the newborn].
    Nevanlinna HR
    Duodecim; 1969; 85(17):986-1003. PubMed ID: 4983455
    [No Abstract]   [Full Text] [Related]  

  • 35. [The passage of maternal rhesus antibodies into the amniotic fluid and its clinical significance].
    Hoffbauer H
    Z Geburtshilfe Gynakol; 1967 Feb; 166(3):290-301. PubMed ID: 4969772
    [No Abstract]   [Full Text] [Related]  

  • 36. Rh immunoglobulin in prevention of hemolytic disease of newborn child.
    Gorman JG
    N Y State J Med; 1983 Jan; 83(1):42-9. PubMed ID: 6402737
    [No Abstract]   [Full Text] [Related]  

  • 37. [Complement activity of blood serum and Rh-isosensitization].
    Sadykov BG; Lineva OI; Ignat'eva DP
    Akush Ginekol (Mosk); 1975 Apr; (4):53-5. PubMed ID: 814833
    [No Abstract]   [Full Text] [Related]  

  • 38. [The significance of agglutinating anti-Rh antibodies in the incidence of hemolytic disease of the newborn (report of a case)].
    Bulcheva B; Spasova K
    Akush Ginekol (Sofiia); 1973; 12(4):328-30. PubMed ID: 4203388
    [No Abstract]   [Full Text] [Related]  

  • 39. [Determination of total complementary activity and of its 4 fractions: C'1, C'2, C'3 and C'4 in the serum and urine].
    Hartmann L; Brécy H
    Ann Biol Clin (Paris); 1969; 27(7):559-70. PubMed ID: 5354248
    [No Abstract]   [Full Text] [Related]  

  • 40. Rh isoimmunization related to amniocentesis.
    Murray JC; Karp LE; Williamson RA; Cheng EY; Luthy DA
    Am J Med Genet; 1983 Dec; 16(4):527-34. PubMed ID: 6419606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.